GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autonomix Medical Inc (NAS:AMIX) » Definitions » Revenue

Autonomix Medical (Autonomix Medical) Revenue : $ Mil (TTM As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Autonomix Medical Revenue?

Autonomix Medical's revenue for the three months ended in Dec. 2023 was $0.00 Mil. Autonomix Medical does not have enough years/quarters to calculate its revenue for the trailing twelve months (TTM) ended in Dec. 2023. Autonomix Medical's Revenue per Share for the three months ended in Dec. 2023 was $0.00. Autonomix Medical does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


Autonomix Medical Revenue Historical Data

The historical data trend for Autonomix Medical's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autonomix Medical Revenue Chart

Autonomix Medical Annual Data
Trend
Revenue

Autonomix Medical Quarterly Data
Dec22 Dec23
Revenue - -

Competitive Comparison of Autonomix Medical's Revenue

For the Medical Devices subindustry, Autonomix Medical's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Autonomix Medical's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Autonomix Medical's Revenue distribution charts can be found below:

* The bar in red indicates where Autonomix Medical's Revenue falls into.



Autonomix Medical Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.


Autonomix Medical  (NAS:AMIX) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Autonomix Medical Revenue Related Terms

Thank you for viewing the detailed overview of Autonomix Medical's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Autonomix Medical (Autonomix Medical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Autonomix Medical Inc is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.